SGLT2 inhibitors (gliflozins) were developed as oral antidiabetics. They enhance urinary glucose excretion by inhibiting SGLT-2 (sodium-dependent glucose co-transporter-2) in the renal tubuli. The discovery of kidney benefits ...
Jun 7, 2021
0
3
Patients with high blood pressure have worse COVID-19 outcomes, and this led to speculation that some anti-hypertensive medications may pose increased risks to patients dealing with hypertension.
May 6, 2021
0
8
Comorbidities such as heart disease, respiratory disease, renal disease and cancer lead to an increased risk of death from COVID-19 according to new research from the University of East Anglia (UEA) and the Norfolk and Norwich ...
Mar 31, 2021
0
10
When COVID-19 was first seen in the United States, now more than a year ago, doctors considered it a respiratory ailment. But that didn't last long.
Feb 11, 2021
0
5
COVID-19 patients who also suffer from high blood pressure are more likely to fall severely ill with the disease, which also leaves them at greater risk of death. Scientists from the Berlin Institute of Health (BIH) and Charité–Universitätsmedizin ...
Jan 11, 2021
0
122
Medications to treat high blood pressure did not affect outcomes among patients hospitalized with COVID-19, found an international team led by researchers in the Perelman School of Medicine at the University of Pennsylvania. ...
Jan 7, 2021
0
74
While the COVID-19 pandemic left the world searching for answers during the earliest stages of the pandemic, one immediate healthcare concern regarded the use of certain antihypertensives—and whether they posed increased ...
Dec 18, 2020
0
2
At the start of the pandemic, there was concern that certain drugs for high blood pressure might be linked with worse outcomes for COVID-19 patients.
Sep 23, 2020
0
30
Early in the onset of the COVID-19 pandemic, a small study in China produced results that influenced subsequent research on the virus. Researchers at the University of Cincinnati used the same study parameters on a much larger ...
Sep 17, 2020
0
164
Heart patients hospitalized with COVID-19 can safely continue taking angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs), according to the BRACE CORONA trial presented in a Hot Line session ...
Sep 1, 2020
0
3
